Finally, the role of potential bias affecting adiponectin levels, including polypharmacy, diabetic kidney disease and other residual or unmeasured confounding factors not taken into account in our study cannot be excluded, thus inviting for caution in interpreting our results. Here, ADIPOQ is linked to diabetic kidney disease.